(Q24241616)

2

0 references

Lex Doyle

object named as

Lex W Doyle

1

0 references

Dwight Rouse

5

object named as

Dwight Rouse

0 references

author name string

Stephane Marret

Cochrane Database of Systematic Reviews

4

0 references

publication date

21 January 2009

0 references

published in

0 references

cites work

Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Benefit of magnesium sulfate given before very preterm birth to protect infant brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Is tocolytic magnesium sulphate associated with increased total paediatric mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

The motor quotient. A method for the early detection of motor delay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium for preventing preterm birth after threatened preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulphate for preventing preterm birth in threatened preterm labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulphate versus lytic cocktail for eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulphate versus diazepam for eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulphate versus phenytoin for eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulphate and other anticonvulsants for women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Mechanisms of asphyxial brain damage, and possible pharmacologic interventions, in the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulfate tocolysis and risk of neonatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Life expectancy in children with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

The effect of maternal magnesium sulfate treatment on neonatal morbidity in < or = 1000-gram infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

A quantitative review of mortality and developmental disability in extremely premature newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium supplementation in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Epidemiology of cerebral palsy in England and Scotland, 1984-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Trends in perinatal mortality and cerebral palsy in Western Australia, 1967 to 1985

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

The aetiology of cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Perinatal risk factors for adverse neurodevelopmental outcome after spontaneous preterm birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Trends in the prevalence of cerebral palsy in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

7 January 2021

Analysis by gestational age of cerebral palsy in singleton births in north-east England 1970-94

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

7 January 2021

Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

7 January 2021

Development and reliability of a system to classify gross motor function in children with cerebral palsy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

7 January 2021

Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

7 January 2021

Primitive reflexes. Their contribution to the early detection of cerebral palsy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004661.PUB3

7 January 2021